Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, ...

Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

Sun Pharma share price dropped 5% after the company posted a mixed bag of results in the March quarter of financial year 2025 ...

OTC Artificial Tears Market Forecasts Report and Company Analysis 2025-2033 Featuring AbbVie, Akorn, Alcon Bausch, Johnson & Johnson, Nicox, Novartis, Santen Pharmaceutical, and Sun Pharmaceutical ...

Mumbai-based Sun Pharma, one of India's oldest drugmakers, which also makes popular consumer healthcare products like Revital ... over-the-counter medications, anti-retrovirals and active ...

The company, which makes popular consumer healthcare products such as Revital ... Founded in 1983, Sun Pharma also makes generics, over-the-counter medications, anti-retrovirals and active ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

Drugmaker Sun Pharmaceutical Industries has completed ... besides other prescription and over-the-counter products., a company note said.

Sun Pharmaceutical Industries Ltd. has lined up a $100 million investment to commercialise innovative products in the current ...